{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:39:18Z","timestamp":1770971958411,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.canep.2025.102805","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:53:15Z","timestamp":1743468795000},"page":"102805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-6091","authenticated-orcid":false,"given":"Juan Felipe","family":"Combariza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2025.102805_bib1","unstructured":"SH S., E C., NL H., ES J., SA P., H S., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues [Internet]. [citado 6 de agosto de 2024]. Disponible en: \u3008https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017\u3009."},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ijc.34618","article-title":"Incidence of Burkitt lymphoma in the United States during 2000 to 2019","volume":"153","author":"Mburu","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.canep.2025.102805_bib4","first-page":"5","article-title":"Epidemiology of Non-Hodgkin\u2019s Lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci. (Basel)"},{"issue":"24","key":"10.1016\/j.canep.2025.102805_bib5","first-page":"4795","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood. 6 De. diciembre De."},{"issue":"8","key":"10.1016\/j.canep.2025.102805_bib6","doi-asserted-by":"crossref","DOI":"10.1200\/GO.21.00265","article-title":"Clinical outcomes of patients with B-cell non-hodgkin lymphoma in real-world settings: findings from the hemato-oncology Latin America Observational Registry Study","author":"Pavlovsky","year":"2022","journal-title":"JCO Glob. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00277-015-2301-7","article-title":"General features and epidemiology of lymphoma in Colombia. A multicentric study","volume":"94","author":"Combariza","year":"2015","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.canep.2025.102805_bib8","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/ijc.30576","article-title":"Survival predictors of Burkitt\u2019s lymphoma in children, adults and elderly in the United States during 2000-2013","volume":"140","author":"Mukhtar","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.canep.2025.102805_bib9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann. Oncol."},{"issue":"20","key":"10.1016\/j.canep.2025.102805_bib10","first-page":"3913","article-title":"Long-term outcome of hyper-CVAD-R for Burkitt leukemia\/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse","volume":"5","author":"Samra","year":"2021","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.canep.2025.102805_bib11","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.20.00303","article-title":"Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated burkitt lymphoma","volume":"38","author":"Roschewski","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canep.2025.102805_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.16425","article-title":"Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients","volume":"189","author":"Jakobsen","year":"2020","journal-title":"Br. J. Haematol. Mayo De."},{"issue":"3","key":"10.1016\/j.canep.2025.102805_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjh.13221","article-title":"Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort","volume":"168","author":"Schommers","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15262","article-title":"Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M\/IVAC plus or minus rituximab","volume":"181","author":"Zhu","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.canep.2025.102805_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/bloodadvances.2018029199","article-title":"Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi","volume":"3","author":"Painschab","year":"2019","journal-title":"Blood Adv. 26"},{"issue":"3","key":"10.1016\/j.canep.2025.102805_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299777","article-title":"Burkitt lymphoma: The effect of age, sex and delay to diagnosis on treatment completion and outcome of treatment in 934 Patients in Cameroon","volume":"19","author":"Hesseling","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.canep.2025.102805_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.anndiagpath.2012.11.001","article-title":"Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina","volume":"17","author":"B\u00fcrgesser","year":"2013","journal-title":"Ann. Diagn. Pathol."},{"issue":"26","key":"10.1016\/j.canep.2025.102805_bib19","article-title":"HIV-related lymphomas in adults served in the public health network: an observational study","volume":"98","author":"da Silva Nascimento","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"5","key":"10.1016\/j.canep.2025.102805_bib20","first-page":"375","article-title":"AIDS and non-Hodgkin\u2019s lymphoma. Experience at an oncological center in Mexico","volume":"60","author":"Cornejo-Ju\u00e1rez","year":"2008","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.canep.2025.102805_bib21","article-title":"Outcomes of HIV-associated Burkitt Lymphoma in Brazil: high treatment toxicity and refractoriness rates - a multicenter cohort study","volume":"89","author":"Silva","year":"2020","journal-title":"Leuk. Res. febrero De."},{"issue":"6-8","key":"10.1016\/j.canep.2025.102805_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/1120009X.2018.1535771","article-title":"Treatment outcomes of adult Burkitt lymphoma: results with a modified LMB protocol in Brazil and feasibility of outpatient administration","volume":"30","author":"Silva Junior","year":"2018","journal-title":"J. Chemother."},{"issue":"4","key":"10.1016\/j.canep.2025.102805_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"issue":"27","key":"10.1016\/j.canep.2025.102805_bib24","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2025.102805_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2025.102805_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2025.102805_bib27","unstructured":"R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria; 2021. Disponible en: \u3008https:\/\/www.R-project.org\/\u3009."},{"issue":"3","key":"10.1016\/j.canep.2025.102805_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00277-020-03908-8","article-title":"In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes","volume":"99","author":"Opie","year":"2020","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.canep.2025.102805_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canep.2025.102805_bib30","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open. 30 De. Agosto De."},{"issue":"1","key":"10.1016\/j.canep.2025.102805_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010","volume":"9","author":"Khan","year":"2014","journal-title":"Infect. Agent Cancer"},{"issue":"19","key":"10.1016\/j.canep.2025.102805_bib32","first-page":"1598","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood. 7 De. noviembre De."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782125000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:31:04Z","timestamp":1747258264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782125000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S1877782125000657"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2025.102805","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2025.102805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102805"}}